Evidence map›Paper›PMID 34557404›Full record

ArticleFrontiers in oncology2021

Malignant Tumor Purity Reveals the Driven and Prognostic Role of

Xiuqin Lu, Chuanyu Li, Wenhao Xu, Yuanyuan Wu, Jian Wang, Shuxian Chen, Hailiang Zhang, Huadong Huang, Haineng Huang, Wangrui Liu

Open access · goldAbstract read
In one paragraph

Article in Frontiers in oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Heliyon · 2023
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Xiuqin LuDepartment of Nursing and Health Management, Shanghai University of Medicine & Health Sciences, Shanghai, China.
Chuanyu LiDepartment of Neurosurgery, Affiliated Hospital of Youjiang Medical University for Nationalities, Guangxi, China.
Wenhao XuDepartment of Urology, Fudan University Shanghai Cancer Center, Shanghai Medical University, Fudan University, Shanghai, China.
Yuanyuan WuDepartment of Gastroenterology, Naval Medical Center of People's Liberation Army (PLA) of China, Naval Military Medical University, Shanghai, China.
Jian WangDepartment of Transplantation, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Shuxian ChenDepartment of Oncology, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Hailiang ZhangDepartment of Urology, Fudan University Shanghai Cancer Center, Shanghai Medical University, Fudan University, Shanghai, China.
Huadong HuangDepartment of Neurosurgery, Affiliated Hospital of Youjiang Medical University for Nationalities, Guangxi, China.
Haineng HuangDepartment of Neurosurgery, Affiliated Hospital of Youjiang Medical University for Nationalities, Guangxi, China.
Wangrui LiuDepartment of Nursing and Health Management, Shanghai University of Medicine & Health Sciences, Shanghai, China.
Affiliated Hospital of Youjiang Medical University for Nationalities · CNFudan University Shanghai Cancer Center · CNShanghai Jiao Tong University · CNShanghai University of Medicine and Health Sciences · CNSecond Military Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The tumor microenvironment (TME) contributes to the initiation and progression of many neoplasms. However, the impact of low-grade glioma (LGG) purity on carcinogenesis remains to be elucidated. We selected 509 LGG patients with available genomic and clinical information from the TCGA database. The percentage of tumor infiltrating immune cells and the tumor purity of LGG were evaluated using the ESTIMATE and CIBERSORT algorithms. Stromal-related genes were screened through Cox regression, and protein-protein interaction analyses and survival-related genes were selected in 487 LGG patients from GEO database. Hub genes involved in LGG purity were then identified and functionally annotated using bioinformatics analyses. Prognostic implications were validated in 100 patients from an Asian real-world cohort. Elevated tumor purity burden, immune scores, and stromal scores were significantly associated with poor outcomes and increased grade in LGG patients from the TCGA cohort. In addition,

Indexed as

CD3Eimmune infiltrationslow-grade gliomaprognosistumor microenvironmenttumor purity

Identifiers

PMID34557404
PMCPMC8454269
OpenAlexW3197968036

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.